223 related articles for article (PubMed ID: 34924312)
1. Applications of the regenerative capacity of platelets in modern medicine.
Cecerska-Heryć E; Goszka M; Serwin N; Roszak M; Grygorcewicz B; Heryć R; Dołęgowska B
Cytokine Growth Factor Rev; 2022 Apr; 64():84-94. PubMed ID: 34924312
[TBL] [Abstract][Full Text] [Related]
2. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro.
Schär MO; Diaz-Romero J; Kohl S; Zumstein MA; Nesic D
Clin Orthop Relat Res; 2015 May; 473(5):1635-43. PubMed ID: 25690170
[TBL] [Abstract][Full Text] [Related]
3. Platelet-Rich Plasma Powder: A New Preparation Method for the Standardization of Growth Factor Concentrations.
Kieb M; Sander F; Prinz C; Adam S; Mau-Möller A; Bader R; Peters K; Tischer T
Am J Sports Med; 2017 Mar; 45(4):954-960. PubMed ID: 27903591
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture.
Toda S; Nishimura T; Yamada S; Koike N; Yonemitsu N; Watanabe K; Matsumura S; Gärtner R; Sugihara H
J Pathol; 1999 Aug; 188(4):415-22. PubMed ID: 10440753
[TBL] [Abstract][Full Text] [Related]
5. A novel virally inactivated human platelet lysate preparation rich in TGF-beta, EGF and IGF, and depleted of PDGF and VEGF.
Burnouf PA; Juan PK; Su CY; Kuo YP; Chou ML; Su CH; Tseng YH; Lin CT; Burnouf T
Biotechnol Appl Biochem; 2010 Aug; 56(4):151-60. PubMed ID: 20608898
[TBL] [Abstract][Full Text] [Related]
6. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?
Miron RJ; Fujioka-Kobayashi M; Hernandez M; Kandalam U; Zhang Y; Ghanaati S; Choukroun J
Clin Oral Investig; 2017 Nov; 21(8):2619-2627. PubMed ID: 28154995
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries.
Middleton KK; Barro V; Muller B; Terada S; Fu FH
Iowa Orthop J; 2012; 32():150-63. PubMed ID: 23576936
[TBL] [Abstract][Full Text] [Related]
8. Cellular Components and Growth Factor Content of Platelet-Rich Plasma With a Customizable Commercial System.
Baria M; Vasileff WK; Miller M; Borchers J; Flanigan DC; Durgam SS
Am J Sports Med; 2019 Apr; 47(5):1216-1222. PubMed ID: 30848659
[TBL] [Abstract][Full Text] [Related]
9. Sustained or higher levels of growth factors in platelet-rich plasma during 7-day storage.
Wen YH; Lin WY; Lin CJ; Sun YC; Chang PY; Wang HY; Lu JJ; Yeh WL; Chiueh TS
Clin Chim Acta; 2018 Aug; 483():89-93. PubMed ID: 29684380
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it].
Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451
[TBL] [Abstract][Full Text] [Related]
11. Role of platelet rich plasma mediated repair and regeneration of cell in early stage of cardiac injury.
Imam SS; Al-Abbasi FA; Hosawi S; Afzal M; Nadeem MS; Ghoneim MM; Alshehri S; Alzarea SI; Alquraini A; Gupta G; Kazmi I
Regen Ther; 2022 Mar; 19():144-153. PubMed ID: 35229012
[TBL] [Abstract][Full Text] [Related]
12. Action of Platelet-Rich Plasma on In Vitro Cellular Bioactivity: More than Platelets.
Beitia M; Delgado D; Mercader J; Sánchez P; López de Dicastillo L; Sánchez M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982439
[TBL] [Abstract][Full Text] [Related]
13. An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: clinical and molecular aspects.
Hajipour H; Farzadi L; Latifi Z; Keyhanvar N; Navali N; Fattahi A; Nouri M; Dittrich R
Syst Biol Reprod Med; 2021 Jun; 67(3):177-188. PubMed ID: 33632047
[TBL] [Abstract][Full Text] [Related]
14. Comparative release of growth factors from PRP, PRF, and advanced-PRF.
Kobayashi E; Flückiger L; Fujioka-Kobayashi M; Sawada K; Sculean A; Schaller B; Miron RJ
Clin Oral Investig; 2016 Dec; 20(9):2353-2360. PubMed ID: 26809431
[TBL] [Abstract][Full Text] [Related]
15. In vitro comparative evaluation of recombinant growth factors for tissue engineering of bladder in patients with neurogenic bladder.
Yang B; Zhou L; Peng B; Sun Z; Dai Y; Zheng J
J Surg Res; 2014 Jan; 186(1):63-72. PubMed ID: 24095026
[TBL] [Abstract][Full Text] [Related]
16. [The use of platelet concentrates: platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in bone reconstruction prior to dental implant surgery].
Baeyens W; Glineur R; Evrard L
Rev Med Brux; 2010; 31(6):521-7. PubMed ID: 21290856
[TBL] [Abstract][Full Text] [Related]
17. Platelet-Rich Plasma in a Murine Model: Leukocytes, Growth Factors, Flt-1, and Muscle Healing.
Denapoli PM; Stilhano RS; Ingham SJ; Han SW; Abdalla RJ
Am J Sports Med; 2016 Aug; 44(8):1962-71. PubMed ID: 27217525
[TBL] [Abstract][Full Text] [Related]
18. Growth factor content in PRP and their applicability in medicine.
Lubkowska A; Dolegowska B; Banfi G
J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):3S-22S. PubMed ID: 23648195
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations.
Oh JH; Kim W; Park KU; Roh YH
Am J Sports Med; 2015 Dec; 43(12):3062-70. PubMed ID: 26473014
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Growth Factors and Fibronectin in Diverse Preparations of Platelet-Rich Plasma for the Treatment of Ocular Surface Disorders (E-PRP).
Rodriguez AE; Gisbert S; Palazón A; Alio JL
Transl Vis Sci Technol; 2020 May; 9(6):22. PubMed ID: 32821519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
